0

Journal Articles

in Amyotrophic Lateral Sclerosis
 1-11 of 11 Articles
Lab Reports |  October 03, 2012
Potential Target for ALS Therapy
Tracy Hampton, PhD
JAMA. 2012;308(13):1310. doi:10.1001/jama.2012.13154.
Lab, Field, and Clinic |  October 12, 2011
New Model System Offers Clues to ALS
Bridget M. Kuehn
JAMA. 2011;306(14):1534. doi:10.1001/jama.2011.1439.
Health Agencies Update |  November 24, 2010
ALS Registry
Bridget M. Kuehn
JAMA. 2010;304(20):2232. doi:10.1001/jama.2010.1682.
Medical News and Perspectives |  September 22, 2010
Troubled by “Stem Cell Tourism” Claims, Group Launches Web-Based Guidance
Mike Mitka
JAMA. 2010;304(12):1315-1316. doi:10.1001/jama.2010.1329.
Capitol Health Call |  November 12, 2008
ALS Registry
Mike Mitka
JAMA. 2008;300(18):2110. doi:10.1001/jama.2008.578.
Perspectives on Care at the Close of Life: CODA |  September 12, 2007
Amyotrophic Lateral Sclerosis:  “Prepare for the Worst and Hope for the Best”
Amy J. Markowitz, JD; Stephen J. McPhee, MD
JAMA. 2007;298(10):1208. doi:10.1001/jama.298.10.1208.
Perspectives on Care at the Close of Life |  July 11, 2007
Palliative Care for Patients With Amyotrophic Lateral Sclerosis:  “Prepare for the Worst and Hope for the Best”
Hiroshi Mitsumoto, MD, DSc; Judith G. Rabkin, PhD, MPH
JAMA. 2007;298(2):207-216. doi:10.1001/jama.298.2.207.
INCLUDES: CME
JAMA Patient Page |  July 11, 2007 FREE
Amyotrophic Lateral Sclerosis
John L. Zeller, MD, PhD; Cassio Lynm, MA; Richard M. Glass, MD
JAMA. 2007;298(2):248. doi:10.1001/jama.298.2.248.
INCLUDES: , Supplemental Content
Medical News and Perspectives |  March 02, 2005
Researchers Coax Human Stem Cells to Become Motor Neurons
JAMA. 2005;293(9):1047-1050. doi:10.1001/jama.293.9.1047.
Medical News and Perspectives |  March 02, 2005
Experimental Therapies Hold Promise for Treating Amyotrophic Lateral Sclerosis
JAMA. 2005;293(9):1048-1049. doi:10.1001/jama.293.9.1048.
Original Contribution |  October 04, 2000 FREE
Linkage of Familial Amyotrophic Lateral Sclerosis With Frontotemporal Dementia to Chromosome 9q21-q22
Betsy A. Hosler, PhD; Teepu Siddique, MD; Peter C. Sapp, BS; et al.
JAMA. 2000;284(13):1664-1669. doi:10.1001/jama.284.13.1664.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Neurology
Original Contribution  |  February 4, 2013
Evaluation of Potential Infectivity of Alzheimer and Parkinson Disease Proteins in Recipients of Cadaver-Derived Human Growth Hormone
David J. Irwin, MD; Joseph Y. Abrams, MPH; Lawrence B. Schonberger, MD, MPH; et al.
JAMA Neurology
Original Contribution  |  February 25, 2013
Incidence of Amyotrophic Lateral Sclerosis Among American Indians and Alaska Natives
Paul H. Gordon, MD, PhD; Jason M. Mehal, MPH; Robert C. Holman, MS; et al.
JAMA Neurology
Original Contribution  |  Mar 2013
Distinct Clinical Characteristics of C9orf72 Expansion Carriers Compared With GRN, MAPT, and Nonmutation Carriers in a Flanders-Belgian FTLD Cohort
Tim Van Langenhove, MD; Julie van der Zee, PhD; Ilse Gijselinck, PhD; et al.
JAMA Neurology
Original Contribution  |  Feb 2013
SOD1 in Cerebral Spinal Fluid as a Pharmacodynamic Marker for Antisense Oligonucleotide Therapy
Leah Winer, BA; Dushyanth Srinivasan, BA; Seung Chun, BA; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems